Clinical Trial Update: Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-Tetrofosmin

View source ↗

Summary

A completed trial assesses the prognostic value of stress SPECT myocardial perfusion imaging using half-dose Tc-99m tetrofosmin in cardiovascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Technetium-99m tetrofosmin (technetium-99m tetrofosmin)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Cardiovascular Disease | Status: COMPLETED